Healthcare Seeking Behavior of Frequent Emergency Care Visitors
NCT ID: NCT05953467
Last Updated: 2024-02-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
700 participants
OBSERVATIONAL
2023-07-11
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Although the Dutch healthcare system is unique with their 24/7 accessibility to primary care, crowding within the acute care chain is a growing problem, even in the Netherlands. Patients visiting an ED multiple times a year, the so called frequent visitors are one of the contributing factors of ED crowding. This relatively small group of patients accounts for a disproportionate number of many ED visits. In the United States, it is estimated that between 4.5 and 8% of patients are responsible for almost one third of the total annual number of ED visits, by visiting the ED four or more times per year. Dutch research by vd Linden found that 0.5% of total ED patients visited their ED frequently, however, they defined frequent visitors using a threshold of 7 visits per year. In our study, the cutoff of more than four visits per year to define a frequent visitor is used.
This study aims to gain insight in who Dutch frequent visitors are, or - in other words - what their baseline characteristics are, which complaints are responsible for their healthcare seeking behavior, and do these patients also seek medical help at other places during out-of-hours like a General Practitioner Cooperative (GPC)?
Existing ED and GCP data will be used to identify patients who either visited the ED or one of the adjacent GPCs 4 times or more in one year. Using these data, this study aims to answer the following questions:
Primary objective:
\- How many patients present to the ED of the Zuyderland hospital in Heerlen and Sittard 4 times or more a year and what are the characteristics of these frequent visitors of the ED?
Secondary objective:
* How many patients present to the GPC of South East Limburg 4 or more times a year and what are their characteristics of frequent visitor?
* Is there an association between the characteristics of frequent visitors of the ED of the Zuyderland hospital and subsequent (frequent) presentation at the GPC?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Stratification in the Emergency Department in Acutely Ill Older Patients
NCT02946398
Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?
NCT00147693
A Descriptive Multicenter Investigation of Geriatrics Hotlines : A French Study
NCT03959475
Case Management Study to Reduce Health Care Utilization for Frequent Hospital Care Users
NCT02583555
Social Robot Support for Healthcare Professionals
NCT03857789
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All patients presenting at the ED or GPC of Zuyderland Medical Center between 1 January 2022 and 31 December 2022, with an age of 18 years or older at time of first presentation during the inclusion period, will be included. Frequent visitors, defined as patients visiting the ED or GPC 4 times or more during these 12 months, will be identified and characterized.
The geography of south east Limburg and the locations of EDs with integrated GPC, ensure that visitors in general visit the same location.
All patients aged 18 years or older at first ED presentation in 2022 will be screened.
Data will be automatically extracted from a digital information system with a retrospective review of patients who visited the ED more than four times in 2022.
Informed consent procedure is not required in this study type (see Data Management).
Patients who have previously stated to the hospital that their data may not be used for scientific research will be excluded.
Data will be extracted from an existing database, providing a retrospective review of all ED and GPC patients. For this study, patients who visited our ED or GPC more than four times in the preceding 12 months will be included. Data will subsequently be collected from their hospital and GPC files and will be anonymized.
Descriptive statistics will be used to present the results. Differences in variables will be statistically analyzed using SPSS. Statistical tests will be chosen dependent on the number of included patients: Chi Square and Fisher Exact tests will be used with a significance p\<0.05.
The following data/variables will be extracted from all patients:
* Age (at first ED or GPC visit during 2022)
* Sex
* Social security number (BSN), which only will be used to link the visitors of the ED and GPC
* Zip code area (only numbers)
* Medical history (chronical pain, oncological, heart/vascular disease, diabetes, psychiatric)
* Service characteristics (date, time of the day (day 8.00-17.00, evening 17.00-24.00), night (24.00-8.00))
* Presenting complaints
Data extracted specifically from ED patients:
* Number of ED visits during inclusion period.
* Triage category (according to the Manchester Triage System: 1-5)
* Mode of referral
* Mode of transportation to hospital (including dispatch center triage urgency)
* Destination: discharge, admission (including type of ward), referral to other clinic, death, leaving without seeing a physician.
* Presenting specialty
* Treating specialism
Data extracted specifically from GPC patients:
* Number of overall visits in 2022
* Urgency level at GPC
* Type of contact: visit, (telephone) consultation
* Treatment given at the GPC
* Referral to secondary care
* Time of contact (evening, night, weekend)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention, observational.
None, observational study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All adult patients aged 18 years or older at first GPC presentation in 2022 who visited the GPC 4 times or more.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zuyderland Medisch Centrum
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zuyderland MC
Heerlen, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
METC Z20230010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.